Advisors Asset Management, Inc. Pacira Bio Sciences, Inc. Transaction History
Advisors Asset Management, Inc.
- $5.23 Billion
- Q4 2024
A detailed history of Advisors Asset Management, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 2,629 shares of PCRX stock, worth $64,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,629
Previous 4,808
45.32%
Holding current value
$64,515
Previous $72,000
31.94%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PCRX
# of Institutions
259Shares Held
49.3MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$196 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$129 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$80.1 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$55.4 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$48.9 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.12B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...